APO RESEARCH · REPORT
Ursodeoxycholic Acid API
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear.
Product & engineering
Understand the product.
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
Selected research
Market Structure
Global Ursodeoxycholic Acid API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
For the application, Ursodeoxycholic Acid API is widely used for Pharmacy and Health Products. The most proportion of Ursodeoxycholic Acid API is used for Pharmacy, and the proportion in 2019 is about 78%.
Read the full market overview
For the regions, Asia-Pacific is the largest consumption place, with a consumption market share nearly 51% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 26%.
For the players, ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Zhongshan belling, Dipharma Francis, etc. are the leaders of the industry.
The report provides an overview of the global Ursodeoxycholic Acid API market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ursodeoxycholic Acid API and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ursodeoxycholic Acid API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ursodeoxycholic Acid API market size, projected growth trends, production technologies, key applications, and end-use industries.
Ursodeoxycholic Acid API Segment by Company
ICE
Grindeks
Mitsubishi
Daewoong chemical
PharmaZell GmbH
Dipharma Francis
Zhangshanbelling
Erregierre
Abil Chempharma
Biotavia Labs
Suzhou Tianlu
Arcelor Chemicals
Ursodeoxycholic Acid API Segment by Type
Synthetic UDCA
Extraction UDCA
Ursodeoxycholic Acid API Segment by Application
Pharmacy
Health Products
Ursodeoxycholic Acid API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ursodeoxycholic Acid API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ursodeoxycholic Acid API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ursodeoxycholic Acid API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ursodeoxycholic Acid API market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ursodeoxycholic Acid API industry.
Chapter 3: Detailed analysis of Ursodeoxycholic Acid API market competition landscape. Including Ursodeoxycholic Acid API manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Ursodeoxycholic Acid API by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Ursodeoxycholic Acid API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Synthetic UDCA
- Extraction UDCA
Applications
- Pharmacy
- Health Products
Companies covered
- ICE
- Grindeks
- Mitsubishi
- Daewoong chemical
- PharmaZell GmbH
- Dipharma Francis
- Zhangshanbelling
- Erregierre
- Abil Chempharma
- Biotavia Labs
- Suzhou Tianlu
- Arcelor Chemicals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Ursodeoxycholic Acid API Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Ursodeoxycholic Acid API Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Ursodeoxycholic Acid API Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Ursodeoxycholic Acid API Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Ursodeoxycholic Acid API Market Dynamics
- 2.1 Ursodeoxycholic Acid API Industry Trends
- 2.2 Ursodeoxycholic Acid API Industry Drivers
- 2.3 Ursodeoxycholic Acid API Industry Opportunities and Challenges
- 2.4 Ursodeoxycholic Acid API Industry Restraints
3 Ursodeoxycholic Acid API Market by Manufacturers
- 3.1 Global Ursodeoxycholic Acid API Production Value by Manufacturers (2021-2026)
- 3.2 Global Ursodeoxycholic Acid API Production by Manufacturers (2021-2026)
- 3.3 Global Ursodeoxycholic Acid API Average Price by Manufacturers (2021-2026)
- 3.4 Global Ursodeoxycholic Acid API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ursodeoxycholic Acid API Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Ursodeoxycholic Acid API Manufacturers, Product Type & Application
- 3.7 Global Ursodeoxycholic Acid API Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ursodeoxycholic Acid API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ursodeoxycholic Acid API Players Market Share by Production Value in 2025
- 3.8.3 2025 Ursodeoxycholic Acid API Tier 1, Tier 2, and Tier 3
4 Ursodeoxycholic Acid API Market by Type
- 4.1 Ursodeoxycholic Acid API Type Introduction
- 4.1.1 Synthetic UDCA
- 4.1.2 Extraction UDCA
- 4.2 Global Ursodeoxycholic Acid API Production by Type
- 4.2.1 Global Ursodeoxycholic Acid API Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ursodeoxycholic Acid API Production by Type (2021-2032)
- 4.2.3 Global Ursodeoxycholic Acid API Production Market Share by Type (2021-2032)
- 4.3 Global Ursodeoxycholic Acid API Production Value by Type
- 4.3.1 Global Ursodeoxycholic Acid API Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ursodeoxycholic Acid API Production Value by Type (2021-2032)
- 4.3.3 Global Ursodeoxycholic Acid API Production Value Market Share by Type (2021-2032)
5 Ursodeoxycholic Acid API Market by Application
- 5.1 Ursodeoxycholic Acid API Application Introduction
- 5.1.1 Pharmacy
- 5.1.2 Health Products
- 5.2 Global Ursodeoxycholic Acid API Production by Application
- 5.2.1 Global Ursodeoxycholic Acid API Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ursodeoxycholic Acid API Production by Application (2021-2032)
- 5.2.3 Global Ursodeoxycholic Acid API Production Market Share by Application (2021-2032)
- 5.3 Global Ursodeoxycholic Acid API Production Value by Application
- 5.3.1 Global Ursodeoxycholic Acid API Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ursodeoxycholic Acid API Production Value by Application (2021-2032)
- 5.3.3 Global Ursodeoxycholic Acid API Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 ICE
- 6.1.1 ICE Company Information
- 6.1.2 ICE Business Overview
- 6.1.3 ICE Ursodeoxycholic Acid API Production, Value and Gross Margin (2021-2026)
- 6.1.4 ICE Ursodeoxycholic Acid API Product Portfolio
- 6.1.5 ICE Recent Developments
- 6.2 Grindeks
- 6.2.1 Grindeks Company Information
- 6.2.2 Grindeks Business Overview
- 6.2.3 Grindeks Ursodeoxycholic Acid API Production, Value and Gross Margin (2021-2026)
- 6.2.4 Grindeks Ursodeoxycholic Acid API Product Portfolio
- 6.2.5 Grindeks Recent Developments
- 6.3 Mitsubishi
- 6.3.1 Mitsubishi Company Information
- 6.3.2 Mitsubishi Business Overview
- 6.3.3 Mitsubishi Ursodeoxycholic Acid API Production, Value and Gross Margin (2021-2026)
- 6.3.4 Mitsubishi Ursodeoxycholic Acid API Product Portfolio
- 6.3.5 Mitsubishi Recent Developments
- 6.4 Daewoong chemical
- 6.4.1 Daewoong chemical Company Information
- 6.4.2 Daewoong chemical Business Overview
- 6.4.3 Daewoong chemical Ursodeoxycholic Acid API Production, Value and Gross Margin (2021-2026)
- 6.4.4 Daewoong chemical Ursodeoxycholic Acid API Product Portfolio
- 6.4.5 Daewoong chemical Recent Developments
- 6.5 PharmaZell GmbH
- 6.5.1 PharmaZell GmbH Company Information
- 6.5.2 PharmaZell GmbH Business Overview
- 6.5.3 PharmaZell GmbH Ursodeoxycholic Acid API Production, Value and Gross Margin (2021-2026)
- 6.5.4 PharmaZell GmbH Ursodeoxycholic Acid API Product Portfolio
- 6.5.5 PharmaZell GmbH Recent Developments
- 6.6 Dipharma Francis
- 6.6.1 Dipharma Francis Company Information
- 6.6.2 Dipharma Francis Business Overview
- 6.6.3 Dipharma Francis Ursodeoxycholic Acid API Production, Value and Gross Margin (2021-2026)
- 6.6.4 Dipharma Francis Ursodeoxycholic Acid API Product Portfolio
- 6.6.5 Dipharma Francis Recent Developments
- 6.7 Zhangshanbelling
- 6.7.1 Zhangshanbelling Company Information
- 6.7.2 Zhangshanbelling Business Overview
- 6.7.3 Zhangshanbelling Ursodeoxycholic Acid API Production, Value and Gross Margin (2021-2026)
- 6.7.4 Zhangshanbelling Ursodeoxycholic Acid API Product Portfolio
- 6.7.5 Zhangshanbelling Recent Developments
- 6.8 Erregierre
- 6.8.1 Erregierre Company Information
- 6.8.2 Erregierre Business Overview
- 6.8.3 Erregierre Ursodeoxycholic Acid API Production, Value and Gross Margin (2021-2026)
- 6.8.4 Erregierre Ursodeoxycholic Acid API Product Portfolio
- 6.8.5 Erregierre Recent Developments
- 6.9 Abil Chempharma
- 6.9.1 Abil Chempharma Company Information
- 6.9.2 Abil Chempharma Business Overview
- 6.9.3 Abil Chempharma Ursodeoxycholic Acid API Production, Value and Gross Margin (2021-2026)
- 6.9.4 Abil Chempharma Ursodeoxycholic Acid API Product Portfolio
- 6.9.5 Abil Chempharma Recent Developments
- 6.10 Biotavia Labs
- 6.10.1 Biotavia Labs Company Information
- 6.10.2 Biotavia Labs Business Overview
- 6.10.3 Biotavia Labs Ursodeoxycholic Acid API Production, Value and Gross Margin (2021-2026)
- 6.10.4 Biotavia Labs Ursodeoxycholic Acid API Product Portfolio
- 6.10.5 Biotavia Labs Recent Developments
- 6.11 Suzhou Tianlu
- 6.11.1 Suzhou Tianlu Company Information
- 6.11.2 Suzhou Tianlu Business Overview
- 6.11.3 Suzhou Tianlu Ursodeoxycholic Acid API Production, Value and Gross Margin (2021-2026)
- 6.11.4 Suzhou Tianlu Ursodeoxycholic Acid API Product Portfolio
- 6.11.5 Suzhou Tianlu Recent Developments
- 6.12 Arcelor Chemicals
- 6.12.1 Arcelor Chemicals Company Information
- 6.12.2 Arcelor Chemicals Business Overview
- 6.12.3 Arcelor Chemicals Ursodeoxycholic Acid API Production, Value and Gross Margin (2021-2026)
- 6.12.4 Arcelor Chemicals Ursodeoxycholic Acid API Product Portfolio
- 6.12.5 Arcelor Chemicals Recent Developments
7 Global Ursodeoxycholic Acid API Production by Region
- 7.1 Global Ursodeoxycholic Acid API Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Ursodeoxycholic Acid API Production by Region (2021-2032)
- 7.2.1 Global Ursodeoxycholic Acid API Production by Region (2021-2026)
- 7.2.2 Global Ursodeoxycholic Acid API Production Forecast by Region (2027-2032)
- 7.3 Global Ursodeoxycholic Acid API Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Ursodeoxycholic Acid API Production Value by Region (2021-2032)
- 7.4.1 Global Ursodeoxycholic Acid API Production Value by Region (2021-2026)
- 7.4.2 Global Ursodeoxycholic Acid API Production Value by Region (2027-2032)
- 7.5 Global Ursodeoxycholic Acid API Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Ursodeoxycholic Acid API Production Value (2021-2032)
- 7.6.2 Europe Ursodeoxycholic Acid API Production Value (2021-2032)
- 7.6.3 Asia-Pacific Ursodeoxycholic Acid API Production Value (2021-2032)
- 7.6.4 South America Ursodeoxycholic Acid API Production Value (2021-2032)
- 7.6.5 Middle East & Africa Ursodeoxycholic Acid API Production Value (2021-2032)
8 Global Ursodeoxycholic Acid API Consumption by Region
- 8.1 Global Ursodeoxycholic Acid API Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Ursodeoxycholic Acid API Consumption by Region (2021-2032)
- 8.2.1 Global Ursodeoxycholic Acid API Consumption by Region (2021-2026)
- 8.2.2 Global Ursodeoxycholic Acid API Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Ursodeoxycholic Acid API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Ursodeoxycholic Acid API Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Ursodeoxycholic Acid API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Ursodeoxycholic Acid API Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Ursodeoxycholic Acid API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Ursodeoxycholic Acid API Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Ursodeoxycholic Acid API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Ursodeoxycholic Acid API Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Ursodeoxycholic Acid API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Ursodeoxycholic Acid API Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Ursodeoxycholic Acid API Value Chain Analysis
- 9.1.1 Ursodeoxycholic Acid API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ursodeoxycholic Acid API Production Mode & Process
- 9.2 Ursodeoxycholic Acid API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ursodeoxycholic Acid API Distributors
- 9.2.3 Ursodeoxycholic Acid API Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst